Results 181 to 190 of about 128,101 (191)

Design, synthesis and biological evaluation of novel 4-phenylisoquinolinone BET bromodomain inhibitors

Bioorganic and Medicinal Chemistry Letters, 2018
Stephen W Káldor, David J Hosfield
exaly  

Structure-guided discovery of a novel, potent, and orally bioavailable 3,5-dimethylisoxazole aryl-benzimidazole BET bromodomain inhibitor

Bioorganic and Medicinal Chemistry, 2019
Richard L Mackman, Jeff Zablocki, Anita Niedziela-Majka   +2 more
exaly  

Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors

Oncogene, 2013
Ramakrishnan Gopalakrishnan
exaly  

Benzopiperazine compositions as BET bromodomain inhibitors

2015
BAIR KENNETH W, HERBERTZ TORSTEN, KAUFFMAN GOSS S, KAYSER-BRICKER KATHERINE J, LUKE GEORGE P, MARTIN MATTHEW W, MILLAN DAVID S, SCHILLER SHAWN E R, TALBOT ADAM C, TEBBE MARK J   +9 more
openaire   +8 more sources

Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer

Nature, 2016
Muhammad B Ekram, Justin M Roberts, Henry W Long   +2 more
exaly  

MECHANISM OF RESISTANCE TO BET BROMODOMAIN INHIBITORS

2017
POLYAK KORNELIA, SHU SHAOKUN, BRADNER JAMES E, LIN CHARLES YANG   +3 more
openaire   +4 more sources

BET Bromodomain Blockade Mitigates Intimal Hyperplasia in Rat Carotid Arteries

EBioMedicine, 2015
Mengxue Zhang, Lian-Wang Guo, Bowen Wang
exaly  

BICYCLIC BET BROMODOMAIN INHIBITORS AND USES THEREOF

2017
STROVEL JEFFREY WILLIAM, YOSHIOKA MAKOTO, MALONEY DAVID J, YANG SHYH MING, JADHAV AJIT, URBAN DANIEL JASON   +5 more
openaire   +5 more sources

FUSED 1,4-DIAZEPINES AS BET BROMODOMAIN INHIBITORS

2018
WANG SHAOMENG, HU JIANTAO, XU FUMING
openaire   +2 more sources

BET bromodomain proteins; smoothened (SMO)

Science-Business eXchange, 2014
openaire   +1 more source